CARLSMED INC (CARL)
Health Care · NASDAQ
Carlsmed develops and commercializes the aprevo Technology Platform, an AI-enabled solution consisting of software, custom-designed interbody implants, and single-use surgical instruments for spine surgery.
What CARLSMED INC does
Carlsmed develops and commercializes the aprevo Technology Platform, an AI-enabled solution consisting of software, custom-designed interbody implants, and single-use surgical instruments for spine surgery. The platform uses artificial intelligence and patient-specific design to provide personalized surgical solutions. The company operates in the medical device space, focused on spinal fusion and related orthopedic procedures. Carlsmed distributes its products through hospitals and surgeon networks in the United States.
Themes: []
Fundamentals
- Price$12.21 as of 2026-07-09 close
- Market cap$332M as of 2026-07-10
- 1-year return-1.1% as of 2026-07-09 close
- Net margin-57.8% as of 2026-07-10
- Gross margin+75.9% as of 2026-07-10
- ROE-40.3% as of 2026-07-10
- Debt / equity0.17 as of 2026-07-10
- Revenue growth (YoY)+58.2% as of 2026-07-10
- Beta2.11 as of 2026-07-10
Key risks (from latest filing)
[]
Competitors & peers
- Medtronic (MDT)
- Stryker (SYK)
- Zimmer Biomet (ZBH)
- NuVasive (NUVA)
- Orthofix International (OFIX)
- LivaNova (LIVN)
- Spinal fusion devices and implants
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.